XML 28 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities:    
Net income (loss) $ 281,459 $ (2,503,438)
Discontinued operations 1,491,004 2,334,811
Net income (loss) from continuing operations (1,209,545) (4,838,249)
Adjustments to reconcile net income (loss) from continuing operations to net cash provided by operating activities:    
Depreciation and amortization expense 3,529,245 3,524,684
Share-based compensation 517,081 805,338
Decrease in non-cash contingent consideration (632,646) (806,390)
Increase (Decrease) In Cash Surrender Value Of Life Insurance Policy (52,070) 169,406
Noncash interest expense 33,943 36,197
Gain on forgiveness of debt (2,187,140) 0
Net changes in assets and liabilities affecting operating activities:    
Accounts receivable 2,527,183 (1,817,490)
Inventories 2,555,393 1,696,668
Other current assets and other assets 1,627,350 1,962,024
Accounts payable and other current liabilities (2,873,596) 3,248,450
Other long-term liabilities (943,439) (1,585,584)
Net cash provided by operating activities from continuing operations 2,891,759 2,395,054
Discontinued operations 1,491,004 2,166,086
Net cash provided by operating activities 4,382,763 4,561,140
Cash flows from investing activities:    
Additions to property and equipment (94,485) (95,189)
Proceeds from surrender of life insurance policies 0 460,888
Note receivable investment funding (200,000) 0
Additions to intangible assets (180,613) (1,807,467)
Net cash used in investing activities (475,098) (1,441,768)
Cash flows from financing activities:    
Borrowings on line of credit 45,000,000 44,000,000
Repayments on line of credit (45,000,000) (45,500,000)
Cash payment of contingent consideration (1,792,573) (834,014)
Repurchase of subsidiary shares from noncontrolling interest 0 (800,000)
Repurchase of common shares (1,025,657) (1,551,463)
Net cash used in financing activities (2,818,230) (4,685,477)
Net increase (decrease) in cash and cash equivalents 1,089,435 (1,566,105)
Cash and cash equivalents at beginning of period 24,753,796 28,212,635
Cash and cash equivalents at end of period $ 25,843,231 $ 26,646,530